Last reviewed · How we verify

azathioprine of 150 [75; 150] mg per day

I.M. Sechenov First Moscow State Medical University · Phase 3 active Small molecule

azathioprine of 150 [75; 150] mg per day is a Immunosuppressant Small molecule drug developed by I.M. Sechenov First Moscow State Medical University. It is currently in Phase 3 development for Prevention of organ rejection in transplant patients, Treatment of autoimmune diseases such as rheumatoid arthritis and lupus.

Azathioprine is an immunosuppressive medication that works by inhibiting the synthesis of purine nucleotides, thereby suppressing the proliferation of T and B lymphocytes.

Azathioprine is an immunosuppressive medication that works by inhibiting the synthesis of purine nucleotides, thereby suppressing the proliferation of T and B lymphocytes. Used for Prevention of organ rejection in transplant patients, Treatment of autoimmune diseases such as rheumatoid arthritis and lupus.

At a glance

Generic nameazathioprine of 150 [75; 150] mg per day
SponsorI.M. Sechenov First Moscow State Medical University
Drug classImmunosuppressant
TargetInosine monophosphate dehydrogenase
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

This mechanism of action is achieved through the inhibition of the enzyme inosine monophosphate dehydrogenase, which is necessary for the synthesis of guanine nucleotides. As a result, azathioprine suppresses the immune system, making it useful for preventing organ rejection in transplant patients and treating autoimmune diseases.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about azathioprine of 150 [75; 150] mg per day

What is azathioprine of 150 [75; 150] mg per day?

azathioprine of 150 [75; 150] mg per day is a Immunosuppressant drug developed by I.M. Sechenov First Moscow State Medical University, indicated for Prevention of organ rejection in transplant patients, Treatment of autoimmune diseases such as rheumatoid arthritis and lupus.

How does azathioprine of 150 [75; 150] mg per day work?

Azathioprine is an immunosuppressive medication that works by inhibiting the synthesis of purine nucleotides, thereby suppressing the proliferation of T and B lymphocytes.

What is azathioprine of 150 [75; 150] mg per day used for?

azathioprine of 150 [75; 150] mg per day is indicated for Prevention of organ rejection in transplant patients, Treatment of autoimmune diseases such as rheumatoid arthritis and lupus.

Who makes azathioprine of 150 [75; 150] mg per day?

azathioprine of 150 [75; 150] mg per day is developed by I.M. Sechenov First Moscow State Medical University (see full I.M. Sechenov First Moscow State Medical University pipeline at /company/i-m-sechenov-first-moscow-state-medical-university).

What drug class is azathioprine of 150 [75; 150] mg per day in?

azathioprine of 150 [75; 150] mg per day belongs to the Immunosuppressant class. See all Immunosuppressant drugs at /class/immunosuppressant.

What development phase is azathioprine of 150 [75; 150] mg per day in?

azathioprine of 150 [75; 150] mg per day is in Phase 3.

What are the side effects of azathioprine of 150 [75; 150] mg per day?

Common side effects of azathioprine of 150 [75; 150] mg per day include Nausea, Vomiting, Diarrhea, Leukopenia, Thrombocytopenia.

What does azathioprine of 150 [75; 150] mg per day target?

azathioprine of 150 [75; 150] mg per day targets Inosine monophosphate dehydrogenase and is a Immunosuppressant.

Related